Medical Procedure News

RSS

Recurrence of breast cancer in older women: Delaying post-surgical radiation treatment increases risk

Older women who have had breast cancer surgery have a greater risk of the cancer returning if they delay their post-surgical radiation treatment, report Dana-Farber Cancer Institute scientists.

4 Mar 2010

Study: Salvage targeted therapy can be suitable for elderly patients with NSCLC

Research published in the March issue of the Journal of Thoracic Oncology sought to determine whether differences existed in tolerance and efficacy between patients age 70 and over and younger patients with non-small cell lung cancer (NSCLC) receiving salvage targeted therapy with epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) or chemotherapy.

4 Mar 2010

CBT effective in treating patients suffering from lupus and high levels of daily stress

This study shows that cognitive behavioural therapy (CBT) is effective in dealing with patients suffering from lupus and high levels of daily stress as it significantly reduces the incidence of psychological disorders associated with lupus and improves and maintains patients' QOL, despite there being no significant reduction in the disease activity index.

3 Mar 2010

New QUANTEC guidelines for safe treatment of cancer with radiation therapy

The culmination of a two-year effort to review available studies and establish new guidelines for the safe treatment of cancer with radiation therapy was published today in the International Journal of Radiation Oncology, Biology and Physics.

3 Mar 2010

RMR can non-invasively, quickly and accurately detect presence of sCAD

Newly published data shows using a Respiratory Modulation Response (RMR) is a novel, non-invasive measure to quickly and accurately detect the presence of significant coronary artery disease (sCAD). Patients in the study with sCAD had a lower RMR compared to patients without, regardless of their risk factors or clinical history of angina, previous myocardial infarction (MI), or angioplasty.

3 Mar 2010

Greater use of ESAs and iron at lower hematocrit levels decrease risk of death for hemodialysis patients

Greater use of erythropoiesis-stimulating agents (ESAs) and more frequent use of iron at lower hematocrit levels (the proportion of the blood that consists of red blood cells) was associated with a decreased risk of death for hemodialysis patients, according to a study in the March 3 issue of JAMA.

3 Mar 2010

CFAS supports the provision of publicly funded IVF and ICSI treatment across Canada

The Canadian Fertility and Andrology Society supports fully the provision of publicly funded in-vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) treatment across Canada. Infertility has been defined by the World Health Organization as a disease of the reproductive system defined by the failure to achieve a clinical pregnancy after 12 months or more of regular unprotected sexual intercourse.

3 Mar 2010

Robotic surgery does not compromise clinical outcomes for prostate cancer surgery

Robotic surgical technology with its three-dimensional, high-definition view gives surgeons the sensation of touch, even as they operate from a remote console. A new study describes the phenomenon, called intersensory integration, and reports that surgical outcomes for prostate cancer surgery using minimally invasive robotic technology compare favorably with traditional invasive surgery.

3 Mar 2010

Medicare coverage of CTC for seniors needed

President Obama, in his first routine physical exam as commander in chief, received a CT colonography (CTC), commonly known as a virtual colonoscopy, to screen him for colorectal cancer. However, Obama Administration officials at the Centers for Medicare and Medicaid Services (CMS) previously denied coverage of the same exam for seniors enrolled in Medicare, cutting off access for many to an exam proven to increase compliance with nationally accepted colon cancer screening guidelines.

3 Mar 2010

Baxter Healthcare's IIPV product recall of HomeChoice peritoneal dialysis cyclers classified as Class I recall

Baxter Healthcare Corporation announced today that the U.S. Food and Drug Administration (FDA) has classified Baxter’s recent Urgent Product Recall regarding Increased Intraperitoneal Volume (IIPV), or overfill of the abdominal cavity, associated with HomeChoice and HomeChoice Pro peritoneal dialysis cyclers as a Class I recall.

From Baxter International Inc. 3 Mar 2010

MRG: Preliminary results from CREST will increase growth in carotid stenting procedures

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, recent preliminary results from the CREST (Carotid Revascularization Endarterectomy versus Stenting Trial) will support growth in carotid stenting procedures of more than 10% over the next five years. The results were announced last week at the American Stroke Association International Stroke Conference 2010.

3 Mar 2010

Vidacare's OnControl Bone Marrow System now available for bone marrow procedures

For many cancer patients, a bone marrow biopsy and/or aspiration is one of the most dreaded aspects of their diagnosis and treatment plan. The traditional method for gaining bone marrow involves grinding a needle by hand and sheer force through a patient’s skin and bone, and the procedure is often described as “brutal,” “excruciating” and even “barbaric.”

3 Mar 2010

Exactech receives FDA marketing clearance for Equinoxe Platform Fracture Stem

Exactech, Inc., a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the company’s Equinoxe® Platform Fracture Stem, the latest addition to the company’s shoulder arthroplasty line.

3 Mar 2010

China's SFDA approves Sunridge International's PNT treatment for glaucoma and ocular hypertension

Sunridge International, announced today that China's State Food and Drug Administration, (SFDA), had approved the firm's Pneumatic Trabeculoplasty (PNT) treatment in China.

3 Mar 2010

OrthoDynamix' ArthroSteer 3.5mm Ablator for general surgical use receives FDA clearance

OrthoDynamix announced today that it has received FDA clearance for its new device, ArthroSteer 3.5mm Ablator, a mono polar electrosurgical device, for general surgical use, including the orthopedic and arthroscopic applications for resection, ablation, excision of soft tissue, hemostasis of blood vessels, and coagulating soft tissue in, but not limited to the knee, shoulder, and primarily the hip.

3 Mar 2010

Corneal transplant surgery: DSAEK leads to greater cell loss overall than PKP

One year post-surgery, patients who underwent Descemet's stripping automated endothelial keratoplasty (DSAEK) experienced greater cell loss overall compared to those who underwent penetrating keratoplasty (PKP), according to a new analysis of data collected from the Cornea Donor Study (CDS) Investigator Group's 2008 Specular Microscopy Ancillary Study (SMAS). However, the study, published in the March issue of Ophthalmology, showed that cell loss in DSAEK patients plateaued more quickly than in those who underwent PKP.

2 Mar 2010

French investigation explores the outcome of physical functioning of coronary angioplasty

A French investigation published in the current issue of Psychotherapy and Psychosomatics has explored the outcome in terms of physical functioning of coronary angioplasty.

2 Mar 2010

St. Jude Medical's Trifecta valve receives CE Mark approval

St. Jude Medical, Inc. today announced that it has received CE Mark approval for the Trifecta™ valve, marking the Company’s launch into the market for pericardial aortic stented tissue valves.

2 Mar 2010

Children with cancer experiencing extreme pain: 13% of parents consider "hastening death"

A survey of parents who had a child die of cancer found that one in eight considered hastening their child's death, a deliberation influenced by the amount of pain the child experienced during the last month of life, report Dana-Farber Cancer Institute researchers in the March issue of Archives of Pediatrics & Adolescent Medicine.

2 Mar 2010

Pre-clinical study of Cardio3 BioSciences' proprietary C-Cath catheter announced

Cardio3 BioSciences, a leading Belgian biotechnology company specialising in cell-based therapies for the treatment of cardiovascular diseases, announced today promising results in a pre-clinical study of its proprietary C-Cath(R) catheter which is under development to administer a range of bio-therapeutics to the heart. C-Cath is designed to take into account organ tissue structure and properties to maximize patients' safety, improve performance and increase user confidence during the injection procedure.

2 Mar 2010

Medical Procedure News

Recurrence of breast cancer in older women: Delaying post-surgical radiation treatment increases risk

Study: Salvage targeted therapy can be suitable for elderly patients with NSCLC

CBT effective in treating patients suffering from lupus and high levels of daily stress

New QUANTEC guidelines for safe treatment of cancer with radiation therapy

RMR can non-invasively, quickly and accurately detect presence of sCAD

Greater use of ESAs and iron at lower hematocrit levels decrease risk of death for hemodialysis patients

CFAS supports the provision of publicly funded IVF and ICSI treatment across Canada

Robotic surgery does not compromise clinical outcomes for prostate cancer surgery

Medicare coverage of CTC for seniors needed

Baxter Healthcare's IIPV product recall of HomeChoice peritoneal dialysis cyclers classified as Class I recall

MRG: Preliminary results from CREST will increase growth in carotid stenting procedures

Vidacare's OnControl Bone Marrow System now available for bone marrow procedures

Exactech receives FDA marketing clearance for Equinoxe Platform Fracture Stem

China's SFDA approves Sunridge International's PNT treatment for glaucoma and ocular hypertension

OrthoDynamix' ArthroSteer 3.5mm Ablator for general surgical use receives FDA clearance

Corneal transplant surgery: DSAEK leads to greater cell loss overall than PKP

French investigation explores the outcome of physical functioning of coronary angioplasty

St. Jude Medical's Trifecta valve receives CE Mark approval

Children with cancer experiencing extreme pain: 13% of parents consider "hastening death"

Pre-clinical study of Cardio3 BioSciences' proprietary C-Cath catheter announced

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News